Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNCA Trial
NCT06353334Phase 4Recruiting
- Start
- Sep 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cardiac arrest (SCA) comparing Butylphthalide with Placebo (2 arms). Primary endpoints: Proportion of patients with Cerebral Performance Category scores of 1-2 at 90 days and Severe Adverse Events at 14 days. Started Sep 2021; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06353334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353334.